Yayınlar & Eserler

Yayın Ağı
Makaleler 46
Tümü (46)
SCI-E, SSCI, AHCI (39)
SCI-E, SSCI, AHCI, ESCI (41)
ESCI (2)
Scopus (40)
TRDizin (7)
Diğer Yayınlar (1)

1. The role of complement C3 deposition in ANCA-associated glomerulonephritis: a registry-based study of clinical, histopathological, and prognostic insights

Uzun S., Gok Oguz E., YILDIZ A., DERİCİ Ü., Cankaya E., Sahin G., et al.
BMC Nephrology , cilt.26, sa.1, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

2. Effect of intradialytic dietary support on nutritional status, muscle strength, and clinical markers in patients on hemodialysis: a cross-sectional study

Usakli S., Mirioglu S., DİNÇER M. T., Karatas B., Karaca C.
BMC Nephrology , cilt.26, sa.1, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

3. A rare case of dual glomerular pathology: Alport syndrome and immune complex-mediated MPGN

Ozcan S. G., Koc E., MURT A., DİNÇER M. T., Gurses I., SEYAHİ N., et al.
BMC NEPHROLOGY , cilt.26, sa.1, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

4. Perioperative Management of Atypical Hemolytic Uremic Syndrome in a Patient on Maintenance Eculizumab Therapy: A Case Report and Review of the Literature.

Mütiş Alan A., Dinçer M. T., Kaykioğlu A., Türk B., Nuhoğlu Kantarci E., Seyahi N., et al.
Nephron , cilt.149, ss.539-544, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

5. Evaluation of Bone Mineral Metabolism in Pre-Dialysis Chronic Kidney Disease: Quantitative Computed Tomography vs. Dual-Energy Absorptiometry and Correlation with Bone Turnover Markers

Mutis Alan A., Sezer Z., Öz A., Karaca C., Dinçer M. T., Murt A., et al.
MEDICINA-LITHUANIA , cilt.61, sa.1, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

6. Optimizing Care for Primary Glomerulonephritis: The Role of Thyroid Evaluation.

Demir A. N., Karaca C., Kara Z., Sulu C., Sahin S., Durcan E., et al.
Endocrine, metabolic & immune disorders drug targets , cilt.25, ss.905-914, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

7. Case of a Rarely Encountered Membranoproliferative Glomerulonephritis:Hepatitis C Associated Cryoglobulinemic Vasculitis

Tanış G., Dinçer M. T., Ak T., Polat A. O., Hürdoğan Ö., Özlük M. Y., et al.
Cerrahpaşa Medical Journal , cilt.49, ss.1-2, 2025 (TRDizin)

8. Does de novo malignancy heighten the risk of rejection in kidney transplant recipients?

Demir E., DİNÇER M. T., KARACA C., Erel C., Karahan L., PEKMEZCİ A., et al.
CLINICAL KIDNEY JOURNAL , sa.12, 2024 (SCI-Expanded, Scopus) identifier identifier

9. Targeting complement dysregulation: eculizumab in scleroderma renal crisis management-a case-based review

TOKER DİNÇER Z., DİNÇER M. T., Sen G., UĞURLU S., SEYAHİ N., SEYAHİ E.
RHEUMATOLOGY INTERNATIONAL , cilt.44, sa.12, ss.3135-3140, 2024 (SCI-Expanded, Scopus) identifier identifier

10. Clinical and histopathological characteristics of primary focal segmental glomerulosclerosis in Turkish adults

KURULTAK İ., Gungor O., Ozturk S., Dirim A. B., EREN N., Yenigün E., et al.
Scientific Reports , cilt.14, sa.1, 2024 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

11. Observational study of immunosuppressive treatment patterns and outcomes in primary membranous nephropathy: a multicenter retrospective analysis

Artan A. S., MİRİOĞLU Ş., Hocaoglu R. H., TURGUTALP K., Boz S. E. G., EREN N., et al.
BMC NEPHROLOGY , cilt.25, sa.1, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

12. Profiling of five urinary exosomal miRNAs for the differential diagnosis of patients with diabetic kidney disease and focal segmental glomerulosclerosis.

Trabulus S., Zor M. S., Alagoz S., Dincer M. T., Meşe M., Yilmaz E., et al.
PloS one , cilt.19, sa.10, 2024 (SCI-Expanded, Scopus) identifier

13. Point-of-Care Ultrasound in Nephrology: A Message from Young Nephrologists

HELVACI Ö., BERKE İ., KUMRU G., DİNÇER M. T., DELİGÖZ BİLDACI Y., Diniz H., et al.
TURKISH JOURNAL OF NEPHROLOGY , sa.4, 2024 (ESCI, TRDizin) identifier

14. Prognostic factors and validation of the histologic chronicity score for C3 glomerulopathy: a registry analysis

Mirioglu S., Cebeci E., Yazici H., DERİCİ Ü., Sahin G., ÇOBAN G., et al.
CLINICAL KIDNEY JOURNAL , cilt.17, sa.8, 2024 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

15. Could mesangial C3 deposition be an independent prognostic marker in immunoglobulin A nephropathy?

Cetinkaya H., GÜRSU M., YAZICI H., Cebeci E., EREN N., ALTIPARMAK M. R., et al.
JOURNAL OF NEPHROLOGY , cilt.37, sa.4, ss.923-932, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

16. Use of tolvaptan in autosomal polycystic kidney disease: A single center experience

Karaca C., Dincer M. T.
ANADOLU KLİNİĞİ TIP BİLİMLERİ DERGİSİ , cilt.28, sa.3, ss.323-328, 2023 (TRDizin) identifier

17. Post-COVID-19 outcomes of non-dialysis dependent chronic kidney disease patients: a national, multicenter, controlled study

Karadag S., Ozturk S., ARICI M., Gorgulu N., Akcali E., Pembegul I., et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY , cilt.55, sa.2, ss.399-408, 2023 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

18. Arteriovenous fistula as the vascular access contributes to better survival of hemodialysis patients with COVID-19 infection

MURT A., Yadigar S., Yalin S. F., DİNCER M. T., Parmaksiz E., ALTIPARMAK M. R.
JOURNAL OF VASCULAR ACCESS , cilt.24, sa.1, ss.22-26, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

19. To what extent can we achieve mineral bone metabolism treatment targets suggested by the KDIGO guidelines among chronic kidney disease stage 3-5 non-dialysis patients?

DİNCER M. T., ÖZCAN Ş. G., Alagoz S., KARACA C., Gulcicek S. H., TRABULUS S., et al.
CLINICAL NEPHROLOGY , cilt.98, sa.5, ss.239-246, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

20. The impact of the COVID-19 pandemic on Fabry Disease Patients: an examination of Mood Status, Therapy Adherence, and COVID-19 infection

KARACA C., DİNCER M. T., ÖZCAN Ş. G., Sarac B., AHMADZADA S., Alagoz S., et al.
ORPHANET JOURNAL OF RARE DISEASES , cilt.17, sa.1, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

21. Renal Manifestations in Inflammatory Bowel Disease: A Cohort Study During the Biologic Era

DİNCER M. T., TOKER DİNCER Z., Bakkaloglu O. K., Yalin S. F., TRABULUS S., ÇELİK A. F., et al.
MEDICAL SCIENCE MONITOR , cilt.28, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

22. Favipiravir therapy for Covid-19 infection and tacrolimus toxicity in a kidney transplant patient on chronic eculizumab therapy

DİNÇER M. T., TRABULUS S., SEYAHİ N.
NATIONAL MEDICAL JOURNAL OF INDIA , cilt.35, sa.4, ss.232-234, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

23. The Longitudinal Evolution of Post-COVID-19 Outcomes Among Hemodialysis Patients in Turkey

Ozturk S., TURGUTALP K., ARICI M., Gorgulu N., TONBUL H. Z., EREN N., et al.
KIDNEY INTERNATIONAL REPORTS , cilt.7, sa.6, ss.1393-1405, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

24. MALIGNANCY AFTER KIDNEY TRANSPLANTATION: A TWO-CENTER

Demir E., DİNCER M. T., KARACA C., Erel C., Karahan L., PEKMEZCİ A., et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.37, 2022 (SCI-Expanded, Scopus) identifier

25. How Dialysis Patients Cope with a Curfew? A Comparison of Psychological Status between Hemodialysis and Peritoneal Dialysis Patients During the COVID-19 Pandemic

KARACA C., EREN N., DİNCER M. T., TURAN Ş., Karaca H. K., Kucuk M., et al.
BLOOD PURIFICATION , cilt.51, sa.5, ss.458-463, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

26. Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia

Durcan E., Ozkan S., Saygi H. I., Dincer M. T., Korkmaz O. P., Sahin S., et al.
JOURNAL OF DIABETES , cilt.14, sa.4, ss.236-246, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

27. Acute Kidney Injury in Cases of COVID-19 Without Existing Kidney Disease: Does It Differ at Various Stages of the Disease?

Murt A., , Dincer M. T., Karaca C., Trabulus S., Karaali R., et al.
Cerrahpaşa Medical Journal , cilt.46, sa.1, ss.35-43, 2022 (TRDizin) Sürdürülebilir Kalkınma

28. A comparison of antibody response in kidney transplant recipients and healthcare workers who had PCR-confirmed COVID-19 infection

DİNÇER M. T., EREN N., MURT A., YILDIZ N., Ozcan S. G., ERGÜL M., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.6, ss.1754-1761, 2022 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier identifier

29. Shall We Use Hydroxychloroquine in Hemodialysis Patients?

MURT A., DİNCER M. T., KARACA C.
BLOOD PURIFICATION , cilt.51, sa.1, ss.97-98, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

30. Blood Pressure Variability in Fabry Disease Patients.

Dincer M. T., Ozcan Ş. G., İkitimur B., Kiykim E., Bakir A., Trabulus S., et al.
Nephron , cilt.146, sa.4, ss.343-350, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

31. Denosumab and Bisphosphonate Treatment of Osteoporosis in Renal Transplant Recipients

Şahin S., , Dinçer M. T., Seyhan D., Bakır A., Korkmaz Ö. P., et al.
Cerrahpasa Medical Journal , cilt.45, sa.3, ss.152-158, 2021 (Hakemli Dergi)

32. Evaluation of the reasons for the microvascular changes in patients with Fabry disease using optic coherence tomography angiography.

Dogan C., Gonen B., Dincer M. T., Mergen B., Kiykim E., Bakir A., et al.
European journal of ophthalmology , cilt.31, sa.6, ss.3231-3237, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

33. The relationship between glomerular IgG staining and poor prognostic findings in patients with IgA nephropathy: the data from TSN-GOLD working group

TURGUTALP K., Cebeci E., Turkmen A., DERİCİ Ü., SEYAHİ N., EREN N., et al.
BMC NEPHROLOGY , cilt.22, sa.1, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

34. Reflex Decay Test Can Reveal Ear Involvement in Fabry Disease

Kiykim E., Kaya M., Dincer M. T., Bakir A., Alagoz S., Aktuglu Zeybek A. Ç., et al.
EAR AND HEARING , cilt.42, sa.5, ss.1351-1357, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

35. Medium Cut-Off Dialysis Membranes: Can They Have Impact on Outcome of COVID-19 Hemodialysis Patients?

Yalın S. F., Altıparmak M. R., Dincer M. T., Yadigar S., Murt A., Parmaksiz E., et al.
Blood purification , cilt.50, ss.921-924, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

36. Augmented Renal Clearance in COVID-19

MURT A., DİNCER M. T., KARACA C.
NEPHRON , cilt.145, sa.4, ss.386-387, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

37. Characteristics of primary glomerular diseases patients with hematuria in Turkey: the data from TSN-GOLD Working Group

Sumnu A., TÜRKMEN K., Cebeci E., Turkmen A., EREN N., Seyahi N., et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY , cilt.53, sa.5, ss.945-954, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

38. Renal Transplant Alıcılarında Osteoporozun Denosumab ve Bisfosfonat Tedavisi

Sahin S., Dincer M. T., Erdoğan D. S., BAKIR A., Korkmaz O. P., DURCAN E., et al.
Cerrahpaşa Medical Journal , cilt.45, sa.3, ss.152-158, 2021 (TRDizin) identifier

39. Kidney function on admission predicts in-hospital mortality in COVID-19.

TRABULUS S., KARACA C., BALKAN İ. İ., DİNCER M. T., MURT A., Ozcan Ş. G., et al.
PloS one , cilt.15, sa.9, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

40. Temporary vocal cord paralysis following hemodialysis catheter placement

MURT A., DİNCER M. T., Karaca C., TRABULUS S., Altiparmak M. R., SEYAHİ N.
HEMODIALYSIS INTERNATIONAL , cilt.24, sa.2, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

41. Evaluation of obstetric outcomes and prognostic significance of graft function in kidney transplant recipient pregnancies

Madazlı R., Kaymak D., Alpay V., Erenel H., Dincer M. T., Seyahi N.
HYPERTENSION IN PREGNANCY , cilt.39, sa.2, ss.89-94, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

42. Prevalence of anemia in predialysis chronic kidney disease: Is the study center a significant factor?

Alagoz S., Dincer M. T., EREN N., Bakir A., Pekpak M., Trabulus S., et al.
PLoS ONE , cilt.15, sa.4, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

43. Temporary bilateral vision loss following cuffed catheter placement with prilocaine anesthesia.

MURT A., DİNCER M. T., Karaca C., SEYAHİ N.
The journal of vascular access , cilt.21, sa.1, ss.128-129, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

44. The relation between body mass index and end organ damage in white coat hypertension

Demir A., Dincer M. T.
MARMARA MEDICAL JOURNAL , cilt.32, sa.1, ss.50-54, 2019 (ESCI, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

45. EVALUATION OF GERIATRIC PATIENTS UNDERWENT EMERGENCY HEMODIALYSIS IN A TERTIARY CARE HOSPITAL

TOKER DİNCER Z., DİNCER M. T., YALIN S. F., TRABULUS S., SEYAHİ N., ALTIPARMAK M. R.
NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.32, 2017 (SCI-Expanded, Scopus) identifier

46. RENAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASES

DİNCER M. T., YALIN S. F., TOKER DİNCER Z., TRABULUS S., SEYAHİ N., ÇELİK A. F., et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.32, 2017 (SCI-Expanded, Scopus) identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 15

1. IMMÜN KONTROL NOKTASI INHIBITÖRLERI ILE TEDAVI EDILEN HASTALARDA IMMÜN ILIŞKILI NEFROPATININ SIKLIĞI: BIR FAERS DATABASE ANALIZI (2020–2024)

Mütiş Alan A., Alan Ö., Dinçer M. T., Murt A., Altıparmak M. R., Seyahi N., et al.
Uluslararası Katılımlı 14. Güncel Böbrek Hastalıkları ve 9. Hipertansiyon, Nefroloji, Diyaliz ve Transplantasyon Kongresi, Muğla, Türkiye, 23 - 27 Nisan 2025, ss.85, (Özet Bildiri) Creative Commons License

2. Does de novo malignancy increase the risk of rejection in kidney transplant recipients?

Demir E., DİNÇER M. T., KARACA C., Erel C., Karahan L., PEKMEZCİ A., et al.
30th International Congress of The Transplantation-Society (TTS), İstanbul, Türkiye, 22 - 25 Eylül 2024, ss.363, (Özet Bildiri) identifier

3. Nadir Gorulen Bir Membranoproliferatif Glomerulonefrit Nedeni: Hepatit C'ye Baglı Kriyoglobulinemik Vaskulit

Tanış G., Dinçer M. T., Ak T., Polat A. O., Seyahi N., Trabulus S., et al.
22. Nefroloji Kış Okulu, Antalya, Türkiye, 7 - 10 Mart 2024, sa.22, (Özet Bildiri)

4. COULD MESANGIAL C3 DEPOSITION BE AN INDEPENDENT PROGNOSTIC MARKER IN IMMUNOGLOBULIN A NEPHROPATHY?

Cetinkaya H., GÜRSU M., YAZICI H., Cebeci E., EREN N., ALTIPARMAK M. R., et al.
60th ERA Congress, Milan, İtalya, 15 - 18 Haziran 2023, (Özet Bildiri) identifier

5. DETERMINANTS OF NON-DIABETIC KIDNEY DISEASES IN DIABETIC PATIENTS

Kır Y., Murt A., Dinçer M. T., Trabulus S., Seyahi N., Altiparmak A. R.
60th ERA Congress, Milan, İtalya, 15 - 18 Haziran 2023, (Özet Bildiri) identifier

6. EVALUATION OF BONE MINERAL STATUS WITH DUAL-ENERGY X-RAY ABSORPTIOMETRY AND QUANTITATIVE COMPUTED TOMOGRAPHY IN CHRONIC RENAL DISEASE

Alan A. M., SEZER Z., Dincer M. T., ÖZ A., Karaca C., ALAGÖZ S., et al.
60th ERA Congress, Milan, İtalya, 15 - 18 Haziran 2023, (Özet Bildiri) identifier

7. ASSOCIATION OF MULTIPLE PLASMA BIOMARKER LEVELS WITH KIDNEY DISEASE ACTIVITY IN FABRY DISEASE

Ozcan S. G., Atli Z., EREN N., DİNÇER M. T., Turkmen K., Ozer H., et al.
60th ERA Congress, Milan, İtalya, 15 - 18 Haziran 2023, (Özet Bildiri) identifier

8. PROGNOSTIC FACTORS AND VALIDATION OF THE HISTOLOGIC CHRONICITY SCORE FOR C3 GLOMERULOPATHY: A REGISTRY ANALYSIS

Mirioglu S., Cebeci E., YAZICI H., DERİCİ Ü., Sahin G. M., EREN N., et al.
60th ERA Congress, Milan, İtalya, 15 - 18 Haziran 2023, (Özet Bildiri) identifier

9. TIME AND THE ETIOLOGY OF ACUTE KIDNEY INJURY DEFINE PROGNOSIS IN THE COURSE OF COVID-19

MURT A., DİNCER M. T., KARACA C., TRABULUS S., SEYAHİ N., ALTIPARMAK M. R.
58th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA), ELECTR NETWORK, 5 - 08 Haziran 2021, cilt.36, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

10. THE IMPACT OF THE COVID-19 PANDEMIC ON MOOD STATUS AND TREATMENT ADHERENCE IN PATIENTS WITH FABRY DISEASE

DİNCER M. T., KARACA C., Sarac B., AHMADZADA S., Bakir A., Alagoz S., et al.
58th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA), ELECTR NETWORK, 5 - 08 Haziran 2021, cilt.36, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

11. CHARACTERISTICS OF PRIMARY GLOMERULAR DISEASE PATIENTS WITH HEMATURIA IN TURKEY: THE DATA FROM TSN-GOLD WORKING GROUP

Sumnu A., TÜRKMEN K., Cebeci E., Turkmen A., EREN N., Seyahi N., et al.
57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 Haziran 2020, cilt.35, ss.757, (Özet Bildiri) identifier

12. IS THE SEVERITY OF GLOMERULAR IGG STAINING IN PATIENT WITH IGA NEPHROPATHY USEFUL FOR PREDICTING POOR RENAL PROGNOSIS? THE DATA FROM TSN-GOLD WORKING GROUP

TURGUTALP K., Cebeci E., Turkmen A., DERİCİ Ü., SEYAHİ N., EREN N., et al.
57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 Haziran 2020, cilt.35, ss.800, (Özet Bildiri) identifier

13. TO WHAT EXTENT CAN WE ACHIEVE MINERAL BONE METABOLISM TREATMENT TARGETS AS SUGGESTED BY UPDATED 2017 KDIGO GUIDELINES IN PATIENTS WITH PREDIALYSIS CHRONIC KIDNEY DISEASE

DİNCER M. T., Ozcan E. G., Alagoz S., KARACA C., Gulcicek S., TRABULUS S., et al.
57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 Haziran 2020, cilt.35, ss.1212, (Özet Bildiri) identifier

14. EFFECTS OF SGLT2 INHIBITORS ON DIABETIC NEPHROPATHY: PODOCYTURIA ON FOCUS

ÖZKAN S., SAYGI H. İ., Korkmaz O. P., DURCAN E., MURT A., ŞAHİN S., et al.
57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 Haziran 2020, cilt.35, ss.1332, (Özet Bildiri) identifier

15. URINARY EXOSOMAL MIRNA LEVELS REVEAL NEW POTENTIAL BIOMARKERS IN TYPE 2 DIABETIC NEPHROPATHY AND FSGS

Trabulus S., Zor M. S., Tahir Turanlı E., Dinçer M. T., Alagöz S., Meşe M., et al.
56th European Renal Associaton-European Dialysis Transplantation Association (ERA-EDTA) Congress, Budapest, Macaristan, 13 - 16 Haziran 2019, cilt.34, ss.214, (Tam Metin Bildiri) Creative Commons License
Metrikler

Yayın

61

Yayın (WoS)

53

Yayın (Scopus)

40

Atıf (WoS)

141

H-İndeks (WoS)

7

Atıf (Scopus)

158

H-İndeks (Scopus)

8

Atıf (Scholar)

23

H-İndeks (Scholar)

3

Proje

2

Açık Erişim

7
BM Sürdürülebilir Kalkınma Amaçları